{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:20:57Z","timestamp":1790720457517,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The human papilloma virus has been associated with anal, cervical, vaginal, and penile cancers. The primary aim of this population-based study is to determine whether HPV-associated cancers are more commonplace in patients with inflammatory bowel disease (IBD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>The Hospital Episode Statistics (HES) database from 1997 to 2012, linked with officer for age standardized rates (ASR), were calculated using population data, and Cox regression analysis was used to determine whether IBD patients have poorer survival compared with non-IBD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 61,648 patients were included in this study; of these, 837 patients had a preexisting diagnosis of IBD (1.4%). Inflammatory bowel disease patients had a significantly higher ASR of anal cancers than the non-IBD population: 5.5 per 100,000 in the IBD group compared with 1.8 in the non-IBD group. The IBD group was also diagnosed with anal cancers at a younger age (60 years compared with 66 years in the non-IBD group, P\u2005&amp;lt;\u20050.001). The survival of IBD patients with anal cancer was also poorer than the non-IBD group (hazard ratio, 1.32; 95% confidence interval, 1.15\u20131.52; P\u2005&amp;lt;\u20050.001). On average, survival was significantly shorter in the IBD group with anal cancer (46 months) compared with the non-IBD group (61 months, P\u2005&amp;lt;\u20050.001). Age standardized rates for cervical cancer was significantly higher in the IBD group (5.2 of 100,000) compared with the non-IBD group (4.6 of 100,000 P\u2005=\u20050.042).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with IBD have a higher rate of anal cancer compared with the general population. Survival is also worse for anal cancers in the IBD group.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izaa035","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T06:39:33Z","timestamp":1582267173000},"page":"34-39","source":"Crossref","is-referenced-by-count":23,"title":["The Incidence and Prevalence of Human Papilloma Virus\u2013associated Cancers in IBD"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9668-0316","authenticated-orcid":false,"given":"Jonathan P","family":"Segal","sequence":"first","affiliation":[{"name":"Inflammatory Bowel Disease Department, St. Mark\u2019s Hospital, Harrow, United Kingdom"},{"name":"Department of Surgery and Cancer, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5993-7613","authenticated-orcid":false,"given":"Alan","family":"Askari","sequence":"additional","affiliation":[{"name":"Department of Surgery, Luton and Dunstable University Hospital, Luton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K","family":"Clark","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Department, St. Mark\u2019s Hospital, Harrow, United Kingdom"},{"name":"Department of Surgery and Cancer, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa L","family":"Hart","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Department, St. Mark\u2019s Hospital, Harrow, United Kingdom"},{"name":"Department of Surgery and Cancer, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar D","family":"Faiz","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Department, St. Mark\u2019s Hospital, Harrow, United Kingdom"},{"name":"Department of Surgery and Cancer, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"2020121505034571300_CIT0001","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.27650","article-title":"EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease","volume":"131","author":"Arbyn","year":"2012","journal-title":"Int J Cancer."},{"key":"2020121505034571300_CIT0002","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine."},{"key":"2020121505034571300_CIT0003","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ejca.2013.06.033","article-title":"Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva","volume":"49","author":"de Sanjos\u00e9","year":"2013","journal-title":"Eur J Cancer."},{"key":"2020121505034571300_CIT0004","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2014.07.018","article-title":"Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples","volume":"50","author":"Alemany","year":"2014","journal-title":"Eur J Cancer."},{"key":"2020121505034571300_CIT0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer."},{"key":"2020121505034571300_CIT0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology."},{"key":"2020121505034571300_CIT0007","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer."},{"key":"2020121505034571300_CIT0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jinf.2012.10.024","article-title":"Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer","volume":"66","author":"Chelimo","year":"2013","journal-title":"J Infect."},{"key":"2020121505034571300_CIT0009","first-page":"233","article-title":"Ulcerative colitis associated with chronic granulomatous disease: case report","volume-title":".","author":"Imanzade","year":"2015"},{"key":"2020121505034571300_CIT0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12016-009-8133-2","article-title":"Crohn\u2019s disease: an immune deficiency state","volume":"38","author":"Marks","year":"2010","journal-title":"Clin Rev Allergy Immunol."},{"key":"2020121505034571300_CIT0011","first-page":"21:1089","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume-title":"Inflamm. Bowel Dis.","author":"Allegretti","year":"2014"},{"key":"2020121505034571300_CIT0012","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"2020121505034571300_CIT0013","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2008.07.005","article-title":"Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation\u2013implications for screening and HPV vaccination","volume":"14","author":"Savani","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"2020121505034571300_CIT0014","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.transproceed.2009.03.015","article-title":"Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data","volume":"41","author":"Veroux","year":"2009","journal-title":"Transplant Proc."},{"key":"2020121505034571300_CIT0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.healun.2003.07.018","article-title":"Sexual health issues after lung transplantation: importance of cervical screening","volume":"23","author":"Malouf","year":"2004","journal-title":"J Heart Lung Transplant."},{"key":"2020121505034571300_CIT0016","first-page":"359","article-title":"Gynecologic malignancies in immunosuppressed organ homograft recipients","volume":"45","author":"Porreco","year":"1975","journal-title":"Obstet Gynecol."},{"key":"2020121505034571300_CIT0017","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn\u2019s disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2020121505034571300_CIT0018","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2013.12.025","article-title":"Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn\u2019s disease","volume":"146","author":"Osterman","year":"2014","journal-title":"Gastroenterology."},{"key":"2020121505034571300_CIT0019","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis."},{"key":"2020121505034571300_CIT0020"},{"key":"2020121505034571300_CIT0021","volume-title":"National Health Service public health functions agreement 2016\u201317 Service specification No.11 Human papillomavirus (HPV) programme"},{"key":"2020121505034571300_CIT0022","article-title":"The global advisory committee on vaccine safety","author":"World Health Organisation.","journal-title":"WHO"},{"key":"2020121505034571300_CIT0023"},{"key":"2020121505034571300_CIT0024","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2147\/IJWH.S50365","article-title":"Long-term efficacy and safety of human papillomavirus vaccination","volume":"6","author":"De Vincenzo","year":"2014","journal-title":"Int J Womens Health."},{"key":"2020121505034571300_CIT0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.2009.09365.x","article-title":"Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease?","volume":"162","author":"Meys","year":"2010","journal-title":"Br J Dermatol."},{"key":"2020121505034571300_CIT0026","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1136\/bmj.e1401","article-title":"Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data","volume":"344","author":"Joura","year":"2012","journal-title":"Bmj."},{"key":"2020121505034571300_CIT0027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2051013613496946","article-title":"The role of human papilloma virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection","volume":"1","author":"Barroso","year":"2013","journal-title":"Ther Adv Vaccines."},{"key":"2020121505034571300_CIT0028","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5694\/j.1326-5377.2008.tb01760.x","article-title":"I want the one for older women - extending the human papillomavirus vaccine population base","volume":"188","author":"Wain","year":"2008","journal-title":"Med J Aust."},{"key":"2020121505034571300_CIT0029","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.crohns.2014.05.006","article-title":"Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature","volume":"8","author":"Duricova","year":"2014","journal-title":"J Crohns Colitis."},{"key":"2020121505034571300_CIT0030","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology."},{"key":"2020121505034571300_CIT0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology."},{"key":"2020121505034571300_CIT0032","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jir281","article-title":"Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses","volume":"204","author":"Westra","year":"2011","journal-title":"J Infect Dis."},{"key":"2020121505034571300_CIT0033","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","author":"Choi","year":"2017","journal-title":"Gut."},{"key":"2020121505034571300_CIT0034","doi-asserted-by":"crossref","first-page":"707","DOI":"10.12968\/hmed.2015.76.12.707","article-title":"Improving the accuracy of HES comorbidity codes by better documentation in surgical admission proforma","volume":"76","author":"Navid","year":"2015","journal-title":"Br J Hosp Med (Lond)."},{"key":"2020121505034571300_CIT0035","doi-asserted-by":"crossref","first-page":"949","DOI":"10.14236\/jhi.v24i4.949","article-title":"Research outputs of England\u2019s Hospital Episode Statistics (HES) database: bibliometric analysis","volume":"24","author":"Chaudhry","year":"2017","journal-title":"J Innov Health Inform."},{"key":"2020121505034571300_CIT0036","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40273-015-0326-3","article-title":"Validation of the hospital episode statistics outpatient data set in England","volume":"34","author":"Thorn","year":"2016","journal-title":"Pharmacoeconomics."},{"key":"2020121505034571300_CIT0037","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/pubmed\/23.3.205","article-title":"A systematic review of discharge coding accuracy","volume":"23","author":"Campbell","year":"2001","journal-title":"J Public Health Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/1\/34\/34907926\/izaa035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/27\/1\/34\/34907926\/izaa035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T10:21:05Z","timestamp":1608027665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/27\/1\/34\/5742067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,2,21]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa035","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,2,21]]}}}